by European Public Health Alliance | Nov 26, 2019 | Opinion
by Vlad Mixich, EPHA Board Member, Romanian Health Observatory The most influential European publication in the health policy area, POLITICO Europe, dedicated an entire panel to the East – West Health Divide during their annual Health Care Summit in...
by European Public Health Alliance | Nov 20, 2019 | Opinion
In April 2011, Mohammed, a software developer based in the United Kingdom and Egypt, developed acute myeloid leukaemia, and while receiving chemotherapy, developed an E.Coli infection. Thanks to a specific combination of high-dose antibiotics, doctors were able to...
by European Public Health Alliance | Oct 24, 2019 | Opinion
By Ellen ‘t Hoen LLM PhD, Medicines Law & Policy Patents and other forms of exclusive rights, such as data exclusivity and market exclusivity, are meant to stimulate innovation by rewarding innovators with temporary monopolies over their innovations. These...
by European Public Health Alliance | Oct 24, 2019 | Opinion
By Charlotte Roffiaen, France Assoc Santé In France, shortages of medicines have regularly made the headlines over the past 12 months. Their numbers have indeed skyrocketed since 2008, from 44 to 868 in 2018, with a further 60% increase expected in 2019. In recent...
by European Public Health Alliance | Oct 24, 2019 | Opinion
By the European Cancer Leagues Access to Medicines Taskforce In 2016 European cancer societies decided to leave their comfort zone and join the access to medicines debate. They established the ECL Access to Medicines Task Force which has since then become an...
by European Public Health Alliance | Oct 24, 2019 | Opinion
Denis Lacombe, Director General, European Organisation for Research and Treatment of Cancer Bringing therapeutic innovation and latest science to patients while keeping patient interests at the centre is a challenging mission. Precision medicine and new approaches to...
